Khalid Abu-Zeinah^1*, Khalil Saadeh, BA^1*, Richard T. Silver, MD², Joseph Scandura, MD, PhD² and Ghaith Abu-Zeinah, MD²

¹University of Cambridge, Cambridge, United Kingdom
²Richard T. Silver, M.D. Myeloproliferative Neoplasms (MPN) Center, Weill Cornell Medicine, New York, NY

Tiziano Barbui^1*, Arianna Ghirardi, BSc^2*, Alessandra Carobbio, BSc^2*, Arianna Masciulli, PhD^2*, Greta Carioli, PhD^2*, Alessandro Rambaldi, MD^3,4, Maria Chiara Finazzi, MD^3,4*, Marta Bellini, MD^3*, Elisa Rumi, MD^5,6*, Daniele Vanni, MD^6*, Oscar Borsani, MD^6*, Francesco Passamonti, MD^7,8*, Barbara Mora, MD^8,9*, Marco Brociner, MD^7*, Alessandro Vannucchi, MD^10,11, Paola Guglielmelli, MD, PhD^10,11, Chiara Paoli, PhD^10,11*, Alberto Alvarez-Larran^12*, Ana Triguero^13*, Marta Garrote, MD^14*, Helna Pettersson, MD^15* and Björn Andréasson, MD, PhD^15*

¹FROM Research Foundation ASST Papa Giovanni XXIII Bergamo, Bergamo, Italy
²FROM Research Foundation Ospedale di Bergamo, Bergamo, Italy
³Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
⁴University of Milan, Milan, Italy
⁵Department of Molecular Medicine, University of Pavia, Pavia, Italy
⁶Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁷Hematology, ASST Sette Laghi, Varese, Italy
⁸University of Insubria, Varese, Italy
⁹Hematology, University Hospital "Ospedale di Circolo e Fondazione Macchi" - ASST Sette Laghi, University of Insubria, Varese, Italy
¹⁰University of Florence, Florence, Italy
¹¹CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, Florence, Italy
¹²Hematology Department, Hematology Department, Hospital ClíNic, Barcelona, Spain
¹³Hospital Clinic of Barcelona, Hematology Department, Barcelona, Spain
¹⁴Hematopathology Unit, Pathology Department, Hospital Clinic, Barcelona, Spain
¹⁵Division of Hematology, NU Hospital Group, Uddevalla, Sweden

Giuseppe Gaetano Loscocco, MD^1*, Paola Guglielmelli, MD, PhD¹, Carmela Mannarelli, PhD^1*, Elena Rossi, MD, PhD^2*, Francesco Mannelli, MD^1*, Francesco Ramundo^2*, Giacomo Coltro, MD^3*, Silvia Betti, MD, PhD^2*, Chiara Maccari^1*, Sara Ceglie, MD^2*, Chiara Paoli, PhD^1*, Tiziano Barbui, MD^4*, Ayalew Tefferi, MD⁵, Valerio De Stefano^6* and Alessandro Vannucchi¹

¹University of Florence, AOU Careggi, CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Italy, Florence, Italy
²Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A Gemelli, IRCCS, Roma, Italy
³University of Florence, AOU Careggi, CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Italy, Florence, Italy, Florence, Italy
⁴FROM Research Foundation Bergamo, Bergamo, Italy
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A Gemelli, IRCCS, Rome, Italy

Ayalew Tefferi, MD¹, Giuseppe Gaetano Loscocco, MD^2*, Faiqa Farrukh, MBBS^3*, Natasha Szuber, MD, MSc⁴, Francesco Mannelli, MD^5*, Animesh D. Pardanani, MBBS, PhD¹, Curtis A. Hanson, MD⁶, Valerio De Stefano^7*, Tiziano Barbui, MD^8*, Paola Guglielmelli, MD, PhD⁹, Naseema Gangat, MBBS¹ and Alessandro Vannucchi¹⁰

¹Division of Hematology, Mayo Clinic, Rochester, MN
²CRIMM,Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Florence, Italy
³Mayo Clinic, Rochester
⁴Hôpital Maisonneuve-Rosemont, Department of Hematology, Montreal, QC, Canada
⁵University of Florence, AOU Careggi, CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Italy, Florence, Italy
⁶Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁷Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A Gemelli, IRCCS, Rome, Italy
⁸Research Foundation, Hospital Papa Giovanni XXIII, Bergamo, Italy,, BERGAMO, Italy
⁹CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, University of Florence, Florence, Italy
¹⁰University of Florence, Firenze, Italy

Aaron T. Gerds, MD, MS¹, Ruben A. Mesa, MD, FACP², John M. Burke, MD³, Michael R. Grunwald, MD⁴, Brady Lee Stein, MD⁵, Robyn Scherber, MD, MPH⁶, Jingbo Yu, MD, PhD⁶, J.E. Hamer-Maansson, MSPH^6* and Stephen Oh, MD, PhD^7*

¹Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
³Rocky Mountain Cancer Centers, Aurora, CO
⁴Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁵Northwestern University Feinberg School, Chicago, IL
⁶Incyte Corporation, Wilmington, DE
⁷Washington University School of Medicine, St. Louis, MO

Douglas Tremblay, MD¹, Andrew Srisuwananukorn, MD¹, Lukas Ronner, MD², Nikolai Podoltsev, MD, PhD³, Jason Gotlib, MD, MS⁴, Mark L. Heaney, MD⁵, Andrew T. Kuykendall, MD⁶, Casey L. O'Connell, MD⁷, Jamile M. Shammo, MD⁸, Angela Fleischman, MD, PhD⁹, Ruben A. Mesa, MD, FACP¹⁰, Abdulraheem Yacoub, MD¹¹, Ronald Hoffman, MD¹², Erin Moshier, MS^13*, Nicole Zubizarreta^13* and John Mascarenhas, MD¹

¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
³Yale University School of Medicine, New Haven, CT
⁴Stanford Cancer Center, Stanford, CA
⁵Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
⁶Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁷Jane Anne Nohl Division of Hematology, University of Southern California, Los Angeles, CA
⁸Division of Hematology/Oncology, Rush Univ. Med. Ctr., Chicago, IL
⁹University of California, Irvine, Irvine, CA
¹⁰Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, TX
¹¹The University of Kansas Cancer Center, Leawood, KS
¹²Tisch Cancer Institute, Icahn School of Medicine At Mount Sinai Medical Center, New York, NY
¹³Department of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY